These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8937972)

  • 1. Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
    Zerva L; Marshall SA; Jones RN
    J Antimicrob Chemother; 1996 Oct; 38(4):742-4. PubMed ID: 8937972
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.
    Watts JL; Salmon SA; Sanchez MS; Yancey RJ
    Antimicrob Agents Chemother; 1997 May; 41(5):1190-2. PubMed ID: 9145899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M; Kinoshita S; Toyama A; Otsuki M; Nishino T
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
    Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
    Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
    McGuirk PR; Jefson MR; Mann DD; Elliott NC; Chang P; Cisek EP; Cornell CP; Gootz TD; Haskell SL; Hindahl MS
    J Med Chem; 1992 Feb; 35(4):611-20. PubMed ID: 1311762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV; LeBlanc B; Gooch G; Ho DH; Bodey GP
    J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Tack KJ; McGuire NM; Eiseman IA
    Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
    Rolston KV; LeBlanc B; Ho DH; Bodey GP
    J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity and pharmacodynamics of new quinolones.
    Dalhoff A; Schmitz FJ
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):203-21. PubMed ID: 12687416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N; Miyakawa Z; Kimura T; Shimizu A; Notake Y; Kunii K
    Drugs; 1995; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinolone antibacterials. An update of their pharmacology and therapeutic use.
    von Rosenstiel N; Adam D
    Drugs; 1994 Jun; 47(6):872-901. PubMed ID: 7521829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antimicrobial activity of sparfloxacin, a new quinolone.
    Paradelis AG; Delidou K; Grigoriadou A; Salpigides G; Pangalis A
    Drugs; 1995; 49 Suppl 2():238-9. PubMed ID: 8549316
    [No Abstract]   [Full Text] [Related]  

  • 13. The quinolones.
    Neu HC
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
    Hayakawa I
    Nihon Rinsho; 1997 May; 55(5):1266-71. PubMed ID: 9155185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of grepafloxacin.
    Wiedemann B; Heisig P
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():19-25. PubMed ID: 9484869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of grepafloxacin against respiratory pathogens in the UK.
    Wise R; Andrews JM
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():27-30. PubMed ID: 9484870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    Zaman MM; Landman D; Burney S; Quale JM
    J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New fluoroquinolones and treatment of acute sinusitis].
    Gehanno P; Trémolières F
    Presse Med; 1999 Sep; 28(25):1365. PubMed ID: 10506868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.